$14.91
-0.40-2.61%
Last update: Nov 11, 4:20 AM
Trevi Therapeutics Inc
TRVINASDAQ
The average analyst price target for Trevi Therapeutics is $22.28, 51.6% above the current price. Of 15 analysts, 15 rate it Buy. Targets range from $7 to $36. The latest change came on Aug 14, 2026, when Jones Trading raised its price target on Trevi Therapeutics from $24 to $28 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 15 Analysts
Rating Trend — Last 9 Months
